Skip to content

Braveheart Bio

US · BRVE #2845 by market cap Listed 2026
20.39 +1.12 +5.81%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Rating change
    A Quick Look at Today's Ratings for Braveheart Bio(BRVE.US), With a Forecast Between $40 to $48
    Market Newswire · 2026/9/1
  • Stifel Nicolaus Remains a Buy on Braveheart Bio, Inc. (BRVE)
    TipRanks · 2026/10/1
  • Rating change
    Analysts Offer Insights on NA Companies: Braveheart Bio, Inc. (BRVE) and TeraWulf Inc (WULF)
    TipRanks · 2026/9/7
  • Stifel Maintains Braveheart Bio(BRVE.US) With Buy Rating, Maintains Target Price $45
    Market Newswire · 2026/11/10
  • Goldman Sachs Maintains Braveheart Bio(BRVE.US) With Buy Rating, Raises Target Price to $49
    Market Newswire · 2026/11/12
  • Braveheart Bio, Inc. (BRVE) Receives a Buy From Cantor Fitzgerald
    TipRanks · 2026/10/20
  • Rating change
    Goldman Sachs Remains a Buy on Braveheart Bio, Inc. (BRVE)
    TipRanks · 2026/9/9
  • Cantor Fitzgerald Maintains Braveheart Bio(BRVE.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/10/20
  • Rating change
    Goldman Sachs Maintains Braveheart Bio(BRVE.US) With Buy Rating, Maintains Target Price $48
    Market Newswire · 2026/9/9
  • Rating change
    Analysts Offer Insights on NA Companies: IMAX (IMAX) and Braveheart Bio, Inc. (BRVE)
    TipRanks · 2026/9/9
  • Stifel Maintains Braveheart Bio(BRVE.US) With Buy Rating, Maintains Target Price $45
    Market Newswire · 2026/10/1

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Braveheart Bio discussion 0 comments

Add a comment